Screening for Biotinidase Deficiency

Ian C.t. Lyon, Edwin A. Mitchell, Elizabeth K. Atherton, Dianne R. Webster, Barry Wolf, Gregory S. Heard, Walter E. Nance

Research output: Contribution to journalLetter

2 Scopus citations

Abstract

To the Editor: Wolf and others1 advocate neonatal screening for biotinidase deficiency. In a feasibility study, we found one infant with a positive test among the 8000 screened. A quantitative plasma assay of biotinidase levels confirmed the result. Levels of biotinidase that were half the normal levels were observed in the mother and in a half-sibling; these findings are consistent with an autosomal recessive inheritance. An examination of the baby at 34 days of age revealed no abnormalities. Biochemical evaluations were normal, as were auditory and visual evoked potentials and an electroretinogram. Treatment was begun with 10 mg of biotin…

Original languageEnglish (US)
Pages (from-to)1457
Number of pages1
JournalNew England Journal of Medicine
Volume314
Issue number22
DOIs
StatePublished - May 29 1986

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Screening for Biotinidase Deficiency'. Together they form a unique fingerprint.

  • Cite this

    Lyon, I. C. T., Mitchell, E. A., Atherton, E. K., Webster, D. R., Wolf, B., Heard, G. S., & Nance, W. E. (1986). Screening for Biotinidase Deficiency. New England Journal of Medicine, 314(22), 1457. https://doi.org/10.1056/NEJM198605293142220